Apollo Hospitals Enterprise Ltd. is Rated Hold

Mar 08 2026 10:10 AM IST
share
Share Via
Apollo Hospitals Enterprise Ltd. is rated 'Hold' by MarketsMojo, with this rating last updated on 09 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.
Apollo Hospitals Enterprise Ltd. is Rated Hold

Current Rating and Its Significance

The 'Hold' rating assigned to Apollo Hospitals Enterprise Ltd. indicates a balanced view of the stock’s prospects. It suggests that while the company demonstrates solid fundamentals and growth potential, certain factors advise caution for investors considering new positions at this time. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Quality Assessment

As of 09 March 2026, Apollo Hospitals maintains a strong quality grade, reflecting its robust operational efficiency and management effectiveness. The company boasts a high Return on Capital Employed (ROCE) of 16.84%, signalling efficient utilisation of capital to generate profits. This level of management efficiency is a positive indicator for long-term investors, underscoring the company’s ability to sustain profitability and growth.

Additionally, Apollo Hospitals has demonstrated consistent positive results over the last nine consecutive quarters. The latest half-year ROCE stands at 16.11%, while quarterly net sales reached a record Rs 6,477.40 crore, and PBDIT hit Rs 965.30 crore. These figures highlight the company’s operational strength and resilience in a competitive healthcare sector.

Valuation Perspective

Currently, the company’s valuation is considered attractive. Apollo Hospitals trades at an Enterprise Value to Capital Employed (EV/CE) ratio of 8.3, which is below the average historical valuations of its peers. This discount suggests that the stock may offer value relative to its sector, making it appealing for investors seeking quality at a reasonable price.

The stock’s Price/Earnings to Growth (PEG) ratio stands at 1.6, reflecting a moderate premium for its earnings growth. Over the past year, Apollo Hospitals has delivered a 23.05% return to shareholders, while profits have increased by 38.7%. This combination of solid returns and attractive valuation supports the 'Hold' rating, signalling that while the stock is not undervalued, it remains a viable investment option with balanced risk and reward.

Financial Trend and Stability

The financial trend for Apollo Hospitals is positive, with healthy long-term growth metrics. Net sales have grown at an annual rate of 17.93%, and operating profit has expanded by 39.35%. The company’s low Debt to EBITDA ratio of 1.48 times indicates a strong ability to service debt, reducing financial risk and enhancing stability.

Institutional investors hold a significant 65.27% stake in the company, reflecting confidence from sophisticated market participants who typically conduct thorough fundamental analysis. This high institutional ownership often contributes to stock price stability and can be a reassuring factor for retail investors.

Technical Analysis

From a technical standpoint, Apollo Hospitals is currently exhibiting a sideways trend. This suggests that the stock price is consolidating within a range, neither showing strong upward momentum nor significant downward pressure. Such a pattern often indicates a period of market indecision, where investors await further catalysts or clearer signals before committing to new positions.

Short-term price movements show a modest decline of 0.61% on the most recent trading day, with a one-week decrease of 1.17%. However, the stock has gained 8.00% over the past month and 7.50% over three months, reflecting underlying strength despite recent volatility.

Performance Relative to Benchmarks

Over the last year, Apollo Hospitals has outperformed the broader BSE500 index, delivering a 23.05% return compared to the benchmark’s lower gains. The company’s consistent returns over the past three years further reinforce its position as a reliable performer within the healthcare sector.

These performance metrics, combined with strong fundamentals and attractive valuation, justify the current 'Hold' rating. Investors are advised to monitor the stock closely for any shifts in technical trends or fundamental developments that could influence future ratings.

Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.

  • - Consistent quarterly delivery
  • - Proven staying power
  • - Stability with growth

See the Consistent Performer →

Implications for Investors

For investors, the 'Hold' rating on Apollo Hospitals Enterprise Ltd. suggests a cautious approach. While the company’s fundamentals remain strong and its valuation attractive, the sideways technical trend and moderate recent price fluctuations indicate that the stock may not offer immediate upside potential. Existing shareholders may consider maintaining their positions to benefit from the company’s steady growth and consistent profitability.

Prospective investors should weigh the stock’s attractive valuation and quality metrics against the current market environment and technical signals. The company’s strong institutional backing and solid financial health provide a degree of confidence, but the sideways price action advises patience and careful monitoring.

Summary

In summary, Apollo Hospitals Enterprise Ltd. is rated 'Hold' by MarketsMOJO as of 09 January 2026, with the latest analysis reflecting data current to 09 March 2026. The rating is supported by the company’s good quality, attractive valuation, positive financial trend, and neutral technical outlook. Investors should consider these factors in the context of their portfolio strategy and risk tolerance.

The company’s consistent operational performance, strong management efficiency, and healthy growth prospects make it a noteworthy stock in the hospital sector. However, the current market dynamics and technical consolidation suggest a prudent stance, aligning with the 'Hold' recommendation.

As always, investors are encouraged to stay informed of any new developments and reassess their positions accordingly.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News